Female induced pluripotent stem cell line – Hepato

£2,000.00

Catalogue Number: SV7IPMD19
Lot Number: 11197
Million / vial

Derived from human skin fibroblasts

Description

Characterised for Pluripotency, spontaneous differentiation to three germ layers and directed differentiation to endoderm-hepatocytes

Product specification

Line History Caucasian 71-Year-Old Female
Cell Type Human Fibroblast derived
Cryopreserved volume 1ml
Storage Liquid Nitrogen
Post Freeze Viability 70-75%
Growth Adherent
Genotype Data available (request further information
Reprogramming Method Non-Integrative Episomal
Reprogramming Conditions Feeder Free, Serum Free, derived using morphological selection

Microbiology/Viral Screening

HIV-1 Negative
HIV-2 Negative
Hepatitis A Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative
Inoculation for microbiological growth Negative

Pluripotency

Stable line characterised for expression of endogenous pluripotency markers, Oct4, Sox2, Nanog, Lin28, Tra1-60, SSEA4.

Transcriptome data available (Request information)

Pluripotency

Differentiation

Trilineage Differentiation assessed through spontaneous differentiation to endoderm, ectoderm and mesoderm derivatives

Directed differentiation to Hepatocyte Like Cells-Liver (request more information)

Differentiation

Reviews

There are no reviews yet.

Be the first to review “Female induced pluripotent stem cell line – Hepato”

Your email address will not be published. Required fields are marked *